Impax
Impax agrees to $35 million settlement over anticompetitive practices with Valeant generic
March 12, 2018Sales and Marketing Impax, Medicis, Solodyn, Valeant, generic, pharma
Impax Pharmaceuticals has acquiesced to paying a $35 million settlement in order to resolve part of an antitrust lawsuit it …
Impax to acquire Teva, Allergan generic drugs for $586 million
June 22, 2016Research and Development, Sales and Marketing Allergan, Impax, Teva, generics
Impax Laboratories (NASDAQ: IPXL) has announced that it has entered into agreements with Teva and affiliates of Allergan to acquire …
Impax cuts staff at troubled California plant
June 11, 2013Manufacturing and Production FDA, Impax, Rytary
US generic drugmaker Impax Laboratories has said it plans to axe a tenth of its workforce and transfer production away …
Impax hit by FDA re-inspection failure
March 11, 2013Manufacturing and Production Impax, hayward
Impax Laboratories has been hit by the news that another (FDA inspection of its troubled manufacturing facility in Hayward, California, …
Shire pays Impax $48 million
February 12, 2013Sales and Marketing ADHD, Adderall, Impax, Shire
Shire has paid $48 million to settle a long-running legal spat with Impax Laboratories over Shire’s supply of an authorised …
Generic approval for Shire’s hyperactivity drug
June 26, 2012Sales and Marketing ADHD, Adderall XR, FDA, IMS Health, Impax, Shire, Teva
US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …
